ClinicaliQ Trial Snapshot
- Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe — Recruiting • Non-phase study • NCT07551986.
- An AI chatbot tested across five European countries to help parents resist vaccine misinformation compared to standard health information.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This multi-country trial evaluates an AI chatbot designed to counter cognitive biases and inoculate parents against vaccine misinformation, embedded within a large survey across five European countries (n=5,000). Scaled from a 2026 single-country study, outcomes compare behavioural and attitudinal responses against standard-of-care materials (e.g., UNICEF infographics) to identify effective, scalable misinformation interventions. Conditions: Healthy Interventions: AI-driven chatbot, Social media infographic Lead Sponsor: London School of Hygiene and Tropical Medicine Planned Enrollment: 5000 participants